"Fuse uses Cure Pharmaceutical, Inc. (“ Cure Pharma ”), as a third party contract manufacturer for its products. Cure Pharma manufacturers Fuse’s products pursuant to a manufacturing agreement at agreed upon cost.
The manufacturing agreement has a term of one year expiring in November 2012, subject to automatic one-year renewals unless terminated by either party upon breach or upon sixty (60) days’ prior written notice.
Manufacturing is conducted in Cure Pharma’s FDA inspected facility in Oxnard, California, which meets cGMP and GLP standards. The manufacturing facility operates with pharmaceutical grade equipment and processes as a standard operating practice, which will allow it to manufacture pharmaceutical grade applications of our technology.
Trade Secrets are maintained within this facility and current capacity will meet the needs of the business in the foreseeable future with adequate space for expansion."
News 
Market Data 
Discover 
